Short answer
NEOGEN CORP (NEOG) filed its Q3 2025 10-Q quarterly report on Oct 9, 2025 for the quarter ended Aug 31, 2025. Quarterly revenue was $209M (down 3.6% year over year) with net income of $36M.
Q3 2025 key financials · XBRL
- Revenue
- $209M
- −3.6% YoY
- Net income
- $36M
- +388.2% YoY
- Operating margin
- -7.7%
- Gross margin
- 45.4%
- EPS (diluted)
- $0.17
- +383.3% YoY
Source: XBRL data from the NEOGEN CORP (NEOG) Q3 2025 10-Q on SEC EDGAR. USD.
NEOGEN CORP Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $209.2M, down $7.8M YoY, primarily from divestitures and discontinued products
- Gross margin 45.4% vs 48.4% YoY
- Food Safety revenue $152.1M, down 5%; Animal Safety revenue $57.1M, down 1%
- Operating cash flow $10.9M vs $(17.9)M YoY; cash $138.9M and revolver availability $201.5M
- $121.7M divestiture proceeds funded $100.0M debt repayment; fiscal 2026 headwinds include tariffs and production inefficiencies
Risk Factors
- New CEO equity awards: 2,104,919 options, restricted stock units, and performance share units granted August 15, 2025
- CEO appointment-related dilution risk: Options exercisable at $5.43 per share with vesting periods of three or four years
- Share repurchase capacity: 5,900,000 shares remained authorized, with zero repurchased during the quarter
- Compliance disclosure: No directors or officers adopted or terminated Rule 10b5-1 trading arrangements during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other NEOGEN CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.